This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: I2 Pharmaceuticals, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Phil Kobel: Innovator in Biopharmaceuticals
Introduction
Phil Kobel is a notable inventor based in San Jose, California. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on binding proteins.
Latest Patents
Phil Kobel holds a patent for "Sur-binding proteins against ERBB3." This patent involves constructs that comprise surrogate light chain sequences. Specifically, it focuses on constructs that can bind to ErbB3 and various aspects related to such constructs. He has 1 patent to his name.
Career Highlights
Phil is currently employed at I2 Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the exploration of therapeutic options targeting the ErbB3 protein.
Collaborations
Phil collaborates with talented professionals in his field, including Ramesh Bhatt and Pamela K. Foreman. Their combined expertise enhances the innovative environment at I2 Pharmaceuticals.
Conclusion
Phil Kobel's contributions to biopharmaceuticals through his patent and collaborative efforts highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile